Prime Medicine will partner with Bristol Myers Squibb (BMS) to develop and commercialize an unspecified number of reagents for ex vivo T-cell therapies through a collaboration that could generate more ...
Prioritizing Set of High Value Programs in Core Areas of Focus; Modularity of Prime Editing Platform Expected to Allow Prime Medicine to Generate Follow-on Candidates Rapidly and Efficiently -- -- ...
A DOCTOR who removed the wrong organ from a patient has a history of errors and has finally had their license suspended. Thomas Shakvovksy was a practicing Osteopathic Physician at Ascension ...
Cystic fibrosis (CF) is a progressive genetic disease that causes persistent lung ... ReCode is expanding its pipeline to develop potential therapies for other rare and common genetic diseases, ...